Revenue
2014
2015
2016
2021
2022
2023
2024
2025
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
Price—Loading quote
Net income
2017
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.1M | $3.5M | $2.0M | $171,169 | $178,146 | — | — | — | $0 | $0 | $773 | $1,249 | $921 | $5,398 | $1,167 |
| Gross profit | $5.1M | $1.1M | $456,517 | −$70,794 | −$97,749 | — | — | — | — | — | — | $1,249 | $921 | $3,260 | $1,167 |
| Research & development | $5.0M | $5.1M | $6.9M | $4.9M | $3.9M | $2.1M | $1.5M | $735,333 | — | — | — | — | — | — | — |
| Operating expenses | $12.4M | $13.0M | $13.9M | $11.9M | $10.2M | $6.8M | $5.8M | $3.1M | $32,611 | $30,915 | $36,687 | $26,342 | $14,654 | $30,688 | $7,211 |
| Operating income | −$4.2M | −$11.9M | −$12.0M | −$10.0M | −$10.2M | −$4.9M | −$5.8M | −$3.1M | −$32,611 | −$30,915 | −$35,914 | −$25,093 | −$13,733 | — | — |
| EBITDAderived | −$4.0M | −$11.6M | −$11.8M | −$9.9M | −$10.1M | −$4.9M | −$5.8M | — | — | — | — | — | — | — | — |
| Net income | −$3.6M | −$12.3M | −$11.9M | −$10.0M | −$9.9M | −$13.6M | −$6.8M | −$5.1M | −$47,775 | −$62,863 | −$36,244 | −$30,554 | −$13,960 | −$27,604 | −$6,044 |
| Basic EPSper diluted share | -$0.09 | -$0.46 | -$0.65 | -$0.63 | -$0.93 | -$2.52 | -$0.57 | -$0.77 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | $0.00 | -$0.01 | — |
| Diluted EPSper diluted share | -$0.09 | -$0.46 | -$0.65 | -$0.63 | -$0.93 | -$2.52 | -$0.57 | -$0.77 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | $0.00 | -$0.01 | — |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 30, 2026Form 4 | Christianson MarkBusiness Development Director | SellCommon Stock | 15.4K | $0.74 | $11.4K | 198.9K |
| Mar 13, 2026Form 4 | Christianson MarkBusiness Development Director | SellCommon Stock | 100 | $0.80 | $80.00 | 214.3K |
| Mar 12, 2026Form 4 | Christianson MarkBusiness Development Director | SellCommon Stock | 817 | $0.80 | $653.60 | 214.4K |
| Mar 11, 2026Form 4 | Christianson MarkBusiness Development Director | SellCommon Stock | 2.1K | $0.80 | $1.7K | 215.2K |
| Mar 10, 2026Form 4 | Christianson MarkBusiness Development Director | SellCommon Stock | 11.6K | $0.80 | $9.3K | 217.3K |